Atlas Trials

A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

Clinical trial NCT04594369 · COMPLETED

Trial details

NCT number
NCT04594369
Sponsor
Insmed Incorporated
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Non-Cystic Fibrosis Bronchiectasis
Start date
2020-12-01
Primary completion
2024-10-28
Enrollment
1767

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.